| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 262.63B | 271.94B | 281.93B | 262.65B | 222.76B | 202.82B |
| Gross Profit | 26.26B | 23.62B | 24.19B | 26.08B | 25.03B | 18.22B |
| EBITDA | 9.86B | 10.67B | 11.24B | 12.63B | 14.35B | 8.70B |
| Net Income | 4.18B | 4.89B | 5.76B | 7.02B | 8.15B | 4.51B |
Balance Sheet | ||||||
| Total Assets | 200.68B | 204.62B | 209.58B | 189.39B | 171.09B | 144.68B |
| Cash, Cash Equivalents and Short-Term Investments | 5.54B | 4.44B | 6.69B | 2.98B | 6.35B | 5.13B |
| Total Debt | 55.02B | 56.73B | 46.76B | 36.35B | 30.09B | 20.17B |
| Total Liabilities | 102.56B | 106.34B | 114.03B | 99.07B | 87.81B | 70.73B |
| Stockholders Equity | 97.22B | 97.39B | 94.73B | 89.62B | 82.63B | 73.72B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -9.42B | -2.26B | -8.21B | -9.61B | 8.90B |
| Operating Cash Flow | 0.00 | 5.76B | 15.94B | -4.39B | -5.14B | 14.63B |
| Investing Cash Flow | 0.00 | -15.64B | -20.78B | 309.00M | -5.04B | -5.66B |
| Financing Cash Flow | 0.00 | 7.63B | 8.66B | 4.60B | 10.46B | -9.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥10.24B | 7.66 | ― | 3.48% | 0.24% | 20.23% | |
69 Neutral | ¥6.35B | -102.51 | ― | 1.06% | 6.41% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥15.18B | 4.33 | ― | 2.87% | 2.38% | -5.80% | |
54 Neutral | ¥20.46B | 3.53 | ― | 4.33% | 5.12% | ― | |
52 Neutral | ¥34.56B | 11.14 | ― | 4.92% | -7.06% | -31.96% | |
45 Neutral | ¥7.76B | -73.23 | ― | ― | -19.32% | -171.53% |